Introduction
Anaplastic large cell lymphoma (ALCL) is characterized by the presence of a cohesive proliferation of large CD30 positive cells with abundant cytoplasm and pleomorphic, often horseshoe shaped nuclei. 1 Most ALCL cases are of the T cell type, but null cell type ALCL also occurs. 2, 3 Two forms of ALCL can be distinguished based on the presence or absence of translocations involving the anaplastic lymphoma kinase (ALK) gene, such as the (2;5)(p23;q35) translocation (NPM/ALK). 4, 5 More recently, variant translocation partners have been described that also lead to overexpression of the ALK protein. 1 ALK positive cases occur more frequently in children and young adults and have a relatively good prognosis with appropriate chemotherapy. ALK negative ALCL occurs in older individuals and has a poor prognosis. 6, 7 Little is known about the biology of this malignant disease and only few studies have been published identifying genes specifically expressed in ALCL. [8] [9] [10] [11] To gain more insight into the genes that are involved in the etiology and pathogenesis of ALCL, we applied serial analysis of gene expression (SAGE). 12 This technique allows the construction of a comprehensive expression profile and results in a quantitative overview of the expression of the genes corresponding to the SAGE tags.
Comparison of the CD4+ALK+ ALCL derived cell line Karpas299 with flow cytometry sorted peripheral blood CD4+ T-cells revealed high expression of Mcl-1 in
Karpas299. Mcl-1 is a member of the Bcl-2 family of apoptosis regulating proteins (including Bcl-2, Bcl-X L , Bcl-X S , Bax, Bak, and Bad) and can inhibit apoptotic cell death. 13, 14 Mcl-1 is also involved in the programming of differentiation, 15 and promotes cell viability. 16 In contrast to the apoptosis inhibiting potential of the full length Mcl-1 transcript, it has been suggested that differential splicing of the Mcl-1 gene yields a shorter protein with a Bcl-2 homology domain 3 that may promote cell death. 17 To study Mcl-1 and other anti-apoptotic Bcl-2 family members Bcl-2 and Bcl-X L we performed real time reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry on ALK+ and ALK− ALCL cases.
Materials and Methods

Cell lines and tissues
CD4+ T-cells were isolated from the buffy coats of healthy donors using a fluorescence activated cell sorter (MoFlo Cytomation, Fort Collins, Colorado, USA) and were used directly for RNA isolation and SAGE analysis. The CD4+ALK+ ALCL derived cell line Karpas299 was obtained from ATCC (Rockville, Maryland, USA) and the NPM/ALK positive ALCL derived cell lines SU-DHL-1, SR786, SUP-M2, and DEL were obtained from DSMZ (Braunschweig, Germany). Based on the presence of the t(2;5) translocation, expression of CD4 and ALK, and lack of expression of B cell markers, we selected the Karpas299 cell line for the SAGE analysis. Frozen and paraffin wax embedded ALCL tissue specimens from 23 ALK+ and nine ALK− ALCL cases were obtained from the departments of pathology of the Groningen University Medical Centre, the Netherlands and the University of Malaysia. All protocols for obtaining and studying human tissues and cells were approved by the institution's review board for human subject research.
SAGE
A detailed protocol for the SAGE procedure and a computer program (SAGE2000 version 4.12) for the analysis of gene specific tags were kindly provided by Dr KW Kinzler (John Hopkins Oncology Center, Baltimore, Maryland, USA). 12 The SAGE procedure was performed as described previously. 18 The SAGE libraries were compared and linked to the Unigene library to identify the corresponding genes. and Mcl-1 targets were normalized relative to the amount of β2m target (∆Ct = ∆Ct (gene) − ∆Ct (β2m) ) and the SD of ∆Ct (SD(∆Ct)) was calculated (SD(∆Ct) = √((SD gene ) 2 + (SD β2m ) 2 ). The relative amount of target gene was measured by determining ∆∆Ct (∆∆Ct = ∆Ct calibrator − ∆Ct testsample ) and the factor difference was calculated (2 −∆∆Ct ). The range is given as 2 −∆∆Ct+SD∆Ct and 2 −∆∆Ct−SD∆Ct . 
Results
We constructed gene expression profiles of Karpas299 and CD4+ T-cells using the SAGE technique. For Karpas299 we sequenced 10 678 tags representing 5090 different genes and for the CD4+ T-cells we obtained 8425 tags representing 4467 (Table 1 ; Fig 2) . The ALK− group included significantly more Bcl-2 (p = 0.004) and Bcl-X L (p = 0.000) positive cases than the ALK+ group. these cells. 32 Similar results were obtained in macrophages and large granular lymphocyte leukemia, which showed reduced Mcl-1 expression upon treatment with JAK inhibitors. 33, 34 Our data indicate the presence of the Mcl-1 protein in all ALCL cases, independent of expression of the ALK protein, which suggests that besides the ALK induced activation of STAT3, other pathways might also contribute to the induction of Mcl-1 expression in ALCL cases that lack ALK expression. This is supported by two studies that show the involvement of the phosphatidylinositol 3kinase pathway in the upregulation of Mcl-1 expression. 33, 35 In addition to positive regulation via survival signals such as activated STAT3 and the phosphatidylinositol 3-kinase pathway, Mcl-1 can also be downregulated via E2F1. 36 
